Oncology Experts

Glenn Bubley

Associate Professor of Medicine
Beth Israel Deaconess Medical Center
United States of America


Glenn Bubley, M.D., is an Associate Professor of Medicine at Beth Israel Deaconess Medical Center in Boston. He went to medical school at Michigan State University College of Human Medicine and completed his residency at Saint Francis Hospital and Medical Center, with a fellowship at Beth Israel Deaconess Medical Center.

Research Interest

Genitourinary Oncology; Prostate Cancer


  • Montgomery B, Tretiakova MS, Joshua AM, Gleave ME, Fleshner N, Bubley GJ, Mostaghel EA, Chi KN, Lin DW, Sanda M, Novotny W. Neoadjuvant enzalutamide prior to prostatectomy. Clinical Cancer Research. 2017 May 1;23(9):2169-76.

  • Bubley GJ, Balk SP. Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide.

  • Zang T, Taplin ME, Tamae D, Xie W, Mesaros C, Zhang Z, Bubley G, Montgomery B, Balk SP, Mostaghel EA, Blair IA. Testicular vs adrenal sources of hydroxy-androgens in prostate cancer. Endocrine-Related Cancer. 2017 Aug 1;24(8):393-404.

Global Experts from United States of America

Global Experts in Subject

Share This Profile